Assessing the efficacy of clinical drugs targeting SARSCoV2 main protease
Nov 06, 2024
Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible omicron variant.
https://phys.org/news/2024-11-efficacy-clinical-drugs-sars-cov.html
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service